Shanghai Haohai Biological Technology Co Ltd
SSE:688366

Watchlist Manager
Shanghai Haohai Biological Technology Co Ltd Logo
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Watchlist
Price: 68.02 CNY -4.06% Market Closed
Market Cap: 13.1B CNY
Have any thoughts about
Shanghai Haohai Biological Technology Co Ltd?
Write Note

Relative Value

The Relative Value of one Shanghai Haohai Biological Technology Co Ltd stock under the Base Case scenario is 119.13 CNY. Compared to the current market price of 68.02 CNY, Shanghai Haohai Biological Technology Co Ltd is Undervalued by 43%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
119.13 CNY
Undervaluation 43%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
90
vs Industry
66
Median 3Y
7.9
Median 5Y
9.3
Industry
8.1
Forward
4.5
vs History
90
vs Industry
6
Median 3Y
58.2
Median 5Y
61.7
Industry
23
Forward
32.3
vs History
90
vs Industry
9
Median 3Y
45.5
Median 5Y
53.6
Industry
23.4
vs History
65
vs Industry
7
Median 3Y
64.4
Median 5Y
66.6
Industry
27.3
vs History
90
vs Industry
42
Median 3Y
3.3
Median 5Y
3.5
Industry
2.6
vs History
90
vs Industry
61
Median 3Y
6.6
Median 5Y
8.2
Industry
8.1
Forward
3.6
vs History
90
vs Industry
54
Median 3Y
9.6
Median 5Y
11.1
Industry
9.6
vs History
90
vs Industry
6
Median 3Y
60.8
Median 5Y
69.5
Industry
4.3
Forward
14.5
vs History
90
vs Industry
6
Median 3Y
60.8
Median 5Y
69.5
Industry
3.8
Forward
17.7
vs History
90
vs Industry
10
Median 3Y
38.1
Median 5Y
44.8
Industry
6
vs History
71
vs Industry
4
Median 3Y
150.4
Median 5Y
190.2
Industry
3.8
vs History
90
vs Industry
46
Median 3Y
3.8
Median 5Y
4.3
Industry
4.8

Multiples Across Competitors

Competitors Multiples
Shanghai Haohai Biological Technology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
13.1B CNY 4.8 29.4 22.8 22.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
300.2B USD 5.4 59 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.4 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD 11.9 -263.9 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 4.1 910.1 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.7 20.8 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 6.3 18.8 17.3 19.2
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
CN
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Average P/E: 181.4
29.4
37%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.1
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.7
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Average EV/EBITDA: 18.6
22.8
122%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.8
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Average EV/EBIT: 23.1
22.8
112%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
25.9
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top